KR20000061959A - a medicine composition contains charcoal powder - Google Patents

a medicine composition contains charcoal powder Download PDF

Info

Publication number
KR20000061959A
KR20000061959A KR1019990011362A KR19990011362A KR20000061959A KR 20000061959 A KR20000061959 A KR 20000061959A KR 1019990011362 A KR1019990011362 A KR 1019990011362A KR 19990011362 A KR19990011362 A KR 19990011362A KR 20000061959 A KR20000061959 A KR 20000061959A
Authority
KR
South Korea
Prior art keywords
weight
powder
charcoal
charcoal powder
pharmaceutical composition
Prior art date
Application number
KR1019990011362A
Other languages
Korean (ko)
Other versions
KR100331885B1 (en
Inventor
유민수
Original Assignee
유민수
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유민수 filed Critical 유민수
Priority to KR1019990011362A priority Critical patent/KR100331885B1/en
Publication of KR20000061959A publication Critical patent/KR20000061959A/en
Application granted granted Critical
Publication of KR100331885B1 publication Critical patent/KR100331885B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: A pharmaceutical composition containing charcoal powder is provided, which is effective especially to a gastroenteric disorder by charcoal effect, and is applicable to various symptoms. CONSTITUTION: A process for the preparation of pharmaceutical composition containing charcoal powder comprises of: burning the oak tree by high temperature of 1200°C, and eliminating gas completelyto get hard charcoal; pulverizing the hard charcoal into 360mesh; pulverizing glutinous unpolished rice into 180mesh; adding adequate quantity of distilled water to charcoal powder 60wt.% and glutinous unpolished rice powder 15wt.%, and emulsifying; adding atractylodes rhizome white powder(180mesh) 10wt.%, barley malt powder(180mesh) 7wt.%, and malted wheat powder 8wt.% to the emulsified compound, and mixing evenly; shaping the compound in the form of pill with 0.5g weight.

Description

숯분말 함유 약제 조성물{a medicine composition contains charcoal powder}Pharmaceutical composition containing charcoal powder {a medicine composition contains charcoal powder}

본 발명은 숯 분말을 함유하는 약제 조성물에 관한 것으로, 좀 더 구체적으로는 흡착력과 해독작용이 강한 숯 분말 40 ∼ 85중량%, 지방으로 오염된 불순물을 제거하는 찹쌀 현미 10 ∼ 27중량%, 비장과 위장을 보호하는 백출가루 7 ∼ 24중량%, 소화효소를 발생하는 맥아 5 ∼ 29중량% 및 위장을 열어주고 담기를 풀어주는 신곡 6 ∼ 27중량%로 구성되어 다양한 증상에 적용 가능한 숯 분말을 함유하는 약제 조성물에 관한 것이다.The present invention relates to a pharmaceutical composition containing charcoal powder, more specifically 40-85 wt% charcoal powder with strong adsorption and detoxification action, 10-27 wt% glutinous rice brown rice to remove impurities contaminated with fat, spleen It is composed of 7 ~ 24% by weight of white crushed powder to protect the stomach and stomach, 5 ~ 29% by weight of malt that produces digestive enzyme, and 6 ~ 27% by weight of new song that opens and releases gastrointestinal tract. It relates to a pharmaceutical composition containing.

일반적으로 숯은 모든 독성 성분을 분해하여 해독 제거할 수 있는 약리 작용과 신진대사를 원활하게 하는 작용이 있어 건강보조식품의 첨가제로 사용되고 있으며, 유해물질과 산성공해에 시달리는 현대인은 누구나 매일 7.5g의 숯 분말을 복용함으로서 인체에 흡착된 모든 유해물질을 제거 해독할 수 있는 것으로 알려져 있다.In general, charcoal is used as an additive in health supplements because it has pharmacological action and metabolism that can detoxify and remove all toxic components, and it is used as an additive of health supplement food. Taking charcoal powder is known to remove and detoxify all harmful substances adsorbed on the human body.

인체에 에너지 공급의 시작점인 위와 장이 오염되면 자율신경의 기능이 저하되고, 장의 기능이 둔화되면 배설이 정상화되지 않기 때문에 음식물이 조금씩 잔류하여 배가 나오고 수종이 일어나 비만의 원인이 되는 것으로 알려지고 있고, 이러한 비만을 치료하기 위해서는 위와 장에 잔류하는 음식물 찌꺼기를 매일 제거하여야 하는데 숯이 가장 효과적인 것으로 밝혀지고 있으며, 비만은 장속의 부패된 단백질과 지방분의 찌꺼기가 장내에 붙어 오래 경과된 산성부패변, 부패가스이므로 이러한 부패숙변을 깨끗이 청소하면 비만의 근원은 자연 소멸되고 영양공급이 원활해 질 뿐만 아니라 혈중농도가 저하되면서 신진대사가 원활해지므로 체질이 개선되어 인체에 불필요한 지방이 없어지면서 깨끗하고 부드러운 피부를 가질 수 있게 된다.When the stomach and intestines, the starting point of energy supply to the human body, are contaminated, the function of the autonomic nerve is reduced, and when the function of the intestines is slowed, the excretion is not normalized. In order to treat such obesity, food residues in the stomach and intestine must be removed every day, and charcoal has been found to be the most effective, and obesity is caused by long-term acid rot and decay due to intestinal decay protein and fat residues. As it is a gas, if you clean these decaying stools, the source of obesity will disappear naturally and nutrient supply will be smooth, and your metabolism will be smoothed as your blood concentration decreases. To have

숯은 확실한 효능이 밝혀지지는 않았지만 위장질환, 소화불량, 위염, 위궤양, 악취제거, 구취, 이질설사, 신경성변비, 아토스성 피부염, 스트레스, 간질환, 당뇨, 고혈압, 체질개선(산성화된 체질을 알카리성 체질로), 해독작용, 지혈작용, 소염 진통, 부기제거, 접골작용, 불면증 등에 효과가 있는 것으로 알려지고 있고, 숙면은 건강 유지에 중요한 요소이지만 각종 스트레스에 시달리는 현대인은 불면증이 수반되어 건강에 해를 끼치는 경우가 허다하였다.Charcoal has not been shown to be effective, but gastrointestinal disorders, indigestion, gastritis, gastric ulcers, odor elimination, bad breath, dysentery diarrhea, neurological constipation, atopic dermatitis, stress, liver disease, diabetes, high blood pressure, and constitution improvement (acidified constitution) Alkaline constitution), detoxification, hemostatic action, anti-inflammatory analgesic, swelling removal, osteopathy, insomnia, etc. are known to be effective, and sleep is an important factor in maintaining health, but modern people suffering from various stresses are accompanied by insomnia Frequently it did harm.

그러나, 베개나 침구에 숯을 이용하므로서 잠자는 동안에 숯에서 발생된 음이온을 체내에 받아들임으로서 짧은 시간에도 숙면을 취할 수 있을 뿐만 아니라 피로회복에 효과적이고, 인체에 산재해 있는 경혈을 자극하여 두통, 고혈압, 눈의 피로회복 뿐만 아니라 음이온의 흡수력으로 면역성이 강화되어 각종 질병으로 부터 저항력을 높일 수 있다.However, by using charcoal on a pillow or bedding, you can take a good night's sleep by taking in the negative ions generated from the charcoal while sleeping, and it is effective for recovery of fatigue and stimulates acupuncture points scattered in the human body, causing headache and high blood pressure. In addition to the recovery of eye fatigue, immunity is enhanced by the absorption of negative ions, thereby increasing resistance from various diseases.

또한, 숯은 탁한 공기를 정화하므로서 인체에 해로운 독소가 정화되어 상쾌하고 명랑해지며, 각종 전자파를 차단하므로서 인체를 보호하고 강력한 흡착력으로 습기를 제거하여 각종 부패를 예방할 수 있게 된다.In addition, charcoal purifies turbid air to purify harmful toxins and refreshing and cheerful, by blocking various electromagnetic waves to protect the human body and to remove moisture by strong adsorptive power to prevent various decay.

상기와 같은 각종 효능 및 효과가 알려지고 있지만 이를 약제로 적용한 경우는 거의 없으며, 피복, 침구 등에 간접적으로 이용하여 숯의 효능을 부여하거나 식품첨가물로 사용되어 각종 부패를 방지하거나 신선도를 유지하며, 맛을 향상시키는 방법들이 알려지고 있다.Although various effects and effects are known as above, they are rarely applied as a medicament, and they are indirectly used for coating or bedding to give the efficacy of charcoal or used as food additives to prevent various decay or maintain freshness, and taste. Ways to improve this are known.

그러나, 숯을 이용한 약제의 개발은 전무한 상태이고, 개발되었다고 하더라도 그 적용에 한계가 있는 등의 문제점이 있었다.However, there is a problem in the development of a drug using the charcoal, and even if developed, there is a limit to its application.

따라서, 본 발명의 목적은 숯에 의한 효과에 의하여 위장질환에 특히 효과적일 뿐만 아니라 다양한 증상에 적용 가능한 숯 분말 함유 약제용 조성물 및 이를 이용한 약제를 제공하는 데 있다.Accordingly, it is an object of the present invention to provide a charcoal powder-containing pharmaceutical composition and a drug using the same, which are particularly effective for gastrointestinal diseases by the effect of charcoal and applicable to various symptoms.

상술한 목적 뿐만 아니라 용이하게 표출될 수 있는 또 다른 목적을 달성하기 위하여 본 발명에서는 흡착력과 해독작용이 강한 숯 분말 40 ∼ 85중량%, 지방으로 오염된 불순물을 제거하는 찹쌀 현미 10 ∼ 27중량%, 비장과 위장을 보호하는 백출가루 7 ∼ 24중량%, 소화효소를 발생하는 맥아 5 ∼ 29중량% 및 위장을 열어주고 담기를 풀어주는 신곡 6 ∼ 27중량%로 구성되는 약제 조성물을 이용하여 약제를 제조하므로서 위장질환에 특히 효과적이면서 다양한 증상에 적용 가능한 숯 분말을 함유하는 약제를 얻을 수 있었다.In order to achieve the above object as well as another object that can be easily expressed in the present invention, 40 to 85% by weight of strong charcoal powder with strong adsorption and detoxification action, 10 to 27% by weight glutinous rice to remove impurities contaminated with fat By using the pharmaceutical composition consisting of 7 to 24% by weight of baekchul powder to protect the spleen and stomach, 5 to 29% by weight of malt generating digestive enzyme, and 6 to 27% by weight of new song to open and release the stomach By preparing the drug was able to obtain a drug containing charcoal powder that is particularly effective in gastrointestinal diseases and applicable to various symptoms.

본 발명을 좀 더 상세히 설명하면 다음과 같다.The present invention is described in more detail as follows.

본 발명에 따른 숯 분말 함유 약제 조성물은 흡착력과 해독작용이 강한 숯 분말 40 ∼ 85중량%, 지방으로 오염된 불순물을 제거하는 찹쌀 현미 10 ∼ 27중량%, 비장과 위장을 보호하는 백출가루 7 ∼ 24중량%, 소화효소를 발생하는 맥아 5 ∼ 29중량% 및 위장을 열어주고 담기를 풀어주는 신곡 6 ∼ 27중량%로 구성되는 것으로 특징지워진다.The charcoal powder-containing pharmaceutical composition according to the present invention is 40 to 85% by weight of strong adsorption and detoxification charcoal powder, 10 to 27% by weight glutinous rice to remove impurities contaminated with fat, 7 to 100 times of white powder to protect the spleen and stomach It is characterized by consisting of 24% by weight, 5 to 29% by weight of malt generating digestive enzymes, and 6 to 27% by weight of new songs which open and release the stomach.

숯 분말은 원목을 약 1200℃ 정도의 고열로 연소시켜 가스를 완전히 제거한 것을 사용하며, 360메쉬 이하의 입도를 갖도록 분쇄한 것을 사용하여야 한다.The charcoal powder is used to remove the gas completely by burning the wood at a high temperature of about 1200 ℃, and should be ground to have a particle size of less than 360 mesh.

숯을 얻기 위한 원목으로는 본 발명이 속하는 기술 분야에서 통상적으로 사용되는 나무를 모두 사용 가능하지만 숯 분말로 부터 발현되는 효능과 효과, 인체에 대한 유해성 등의 측면을 고려할 때 참나무와 대나무가 가장 효과적이었다.As a timber for obtaining charcoal, all trees commonly used in the technical field of the present invention can be used, but oak and bamboo are most effective when considering aspects such as efficacy and effect expressed from charcoal powder and harmfulness to human body. It was.

원목을 약 1200℃ 정도의 고열로 연소시켜 가스를 완전히 제거하지 않은 경우에는 분쇄가 용이하지 못할 뿐만 아니라 원목에 잔류하는 여러 가지 성분 중 인체에 해를 끼치는 성분이 함유되어 있어 바람직하지 못하며, 360메쉬 이하의 입도를 갖도록 분쇄하지 않을 경우에는 물에 첨가하였을 때 즉시 분해되지 않기 때문에 인체에 해를 끼치는 단점이 있다.If the wood is burned at a high temperature of about 1200 ℃ and the gas is not completely removed, it will not be easy to grind, and it is not preferable because it contains components that harm the human body. If it is not pulverized to have the following particle size, it does not decompose immediately when added to water has a disadvantage that harms the human body.

숯 분말은 40 ∼ 85중량%를 사용하는 것이 효과적이고, 55중량% 미만으로 사용될 경우에는 숯 분말로 부터 발현되는 효과가 미약한 단점이 있고, 72중량%를 초과하여 사용될 경우에는 다른 성분들이 소량으로 사용되기 때문에 다른 성분으로 부터 발현되는 효과를 얻을 수 없을 뿐만 아니라 각종 제형의 약제로 제조하기 어려운 단점이 있다.It is effective to use 40 to 85% by weight of charcoal powder, and when used in less than 55% by weight, there is a disadvantage that the effect from the charcoal powder is weak, and when it is used in excess of 72% by weight, small amounts of other ingredients are used. Because it is used as not only can not obtain the effect expressed from other components, there are disadvantages that are difficult to prepare a drug of various formulations.

찹쌀 현미는 지방으로 오염된 불순물을 제거하는 효과가 있는 것으로 분쇄하여 수분을 첨가하고 균질하게 혼합하여 에멀젼(emulsion) 상태로 사용하므로서 찹쌀 현미로 부터 발현되는 효과유지는 물론 각종 제형의 약제로 제조하기 용이하게 하는 작용을 한다.Glutinous rice brown rice has the effect of removing impurities contaminated with fat. It is crushed to add water and mixed homogeneously to be used in emulsion (emulsion) to maintain the effects expressed from glutinous rice brown rice as well as to prepare as a pharmaceutical of various formulations It acts to facilitate.

찹쌀 현미 역시 360메쉬 이하로 분쇄한 것을 사용하는 것이 인체에 투여된 후 흡수가 신속히 일어나고 경구 투여시에 이질감을 느끼지 않으며, 10 ∼ 27중량%를 사용하는 것이 효과적이다.Glutinous rice brown rice also used to be pulverized to less than 360 mesh is absorbed quickly after administration to the human body does not feel heterogeneity when administered orally, it is effective to use 10 to 27% by weight.

찹쌀 현미의 사용량이 10중량% 미만일 경우에는 약제를 일정 제형으로 제조하기가 용이하지 못할 뿐만 아니라 찹쌀 현미로 부터 발현되는 효과가 미약한 단점이 있고, 27중량%를 초과하여 사용될 경우에는 숯 분말로 부터 발현되는 효과가 미약한 문제점이 있고 기타 성분들이 균질하게 혼합되지 못하고 뭉치는 경향이 있어 바람직하지 못하다.When the amount of glutinous rice brown rice is less than 10% by weight, it is not easy to prepare the drug in a certain formulation, and there is a weak effect that is expressed from glutinous rice brown rice, and when used in excess of 27% by weight as charcoal powder There is a weak effect that is expressed from the other components are not preferable because they do not homogeneously mix and tend to aggregate.

백출은 국화과에 속하는 큰참삽주(Atractylodes macrocephala) 및 동속의 근경으로서 10월 하순에서 11월 상순경에 채취하여 줄기를 제거하고 흙을 털어낸 후 햇볕에 건조하거나 화건한 다음, 수염뿌리를 제거하고 다시 양건이나 화건한 것을 사용하며, 예로 부터 신체허약, 비위허약, 식욕부진, 위내정수, 풍습성관절염, 자한, 부종 등에 응용되어 왔다.Baekchul is an Atractylodes macrocephala belonging to the Asteraceae family. It is collected at the end of October to the beginning of November to remove stems, shake off the soil, dry it in the sun or dry it, remove the beard roots, It is used for both tendon and unhealthy, and has been applied to physical weakness, nausea weakness, anorexia, gastrointestinal sperm, customary arthritis, cold and edema.

본 발명에서는 백출 고유의 효능, 효과 뿐만 아니라 다른 성분들이 뭉치는 것을 방지하는 작용을 하는 것으로 360메쉬 이하로 분쇄한 것을 사용하는 것이 인체에 투여된 후 흡수가 신속히 일어나고 경구 투여시에 이질감을 느끼지 않으며, 7 ∼ 24중량%를 사용하는 것이 효과적이다.In the present invention, the use of pulverized to less than 360 mesh to the effect of preventing the aggregation of other components as well as inherent efficacy and effect of the extraction is rapidly absorbed after administration to the human body does not feel heterogeneity in oral administration , It is effective to use 7 to 24% by weight.

백출 분말의 사용량이 24중량% 초과할 경우에는 백출로 부터 발현되는 효과가 미약한 단점이 있고, 7중량% 미만으로 사용될 경우에는 숯 분말로 부터 발현되는 효과가 미약한 문제점이 있고 기타 성분들이 균질하게 혼합되지 못하고 뭉치는 경향이 있어 바람직하지 못하다.When the amount of the white powder is more than 24% by weight, the effect expressed from white rice is insignificant. If the amount is less than 7% by weight, the effect from the charcoal powder is weak and other components are homogeneous. It is not desirable because it does not mix well and tends to aggregate.

맥아는 밀, 보리 따위에 물을 부어 싹이 나게 한 다음 건조한 것으로 아밀라제라는 가수분해효소가 풍부하여 소화를 돕는 작용을 하는 것으로 360메쉬 이하로 분쇄한 것을 사용하는 것이 제조되는 약제가 인체에 투여된 후 신속하게 분해되어 인체에 손쉽게 흡수되도록 하고 경구 투여시에 이질감을 느끼지 않으며, 5 ∼ 29중량%를 사용하는 것이 효과적이다.Malt is sprouted by pouring water on wheat and barley and then dried. It is rich in a hydrolase called amylase, which helps digestion. It is quickly decomposed to be easily absorbed by the human body and does not feel heterogeneity in oral administration, and it is effective to use 5 to 29% by weight.

맥아가 5중량% 미만으로 사용될 경우에는 다른 성분들의 분해가 잘 이루어지지 않고 소화가 용이하게 이루어지지 않아 인체에 유용한 효과를 나타내는 성분이 그대로 인체 밖으로 배출되어 효과적이지 못하고, 29중량%를 초과하여 사용될 경우에는 경제적이지 못하며 다른 성분들의 사용량이 상대적으로 감소되어 본 발명에서 목적하는 효과를 얻을 수 없다.When malt is used in less than 5% by weight, other components are not easily decomposed and are not easily digested, and the components showing useful effects on the human body are discharged out of the human body as they are, which is not effective, and used in excess of 29% by weight. In this case, it is not economical and the amount of other components used is relatively reduced, so that the desired effect can not be obtained in the present invention.

신곡은 쌀,보리,조,누룩을 의미하는 것으로 제조되는 약제에 맛과 향을 부여하기 위하여 첨가되는 것으로 사람이 섭취할 수 있는 각종 곡물로 구성되는 군으로 부터 적어도 1종 이상을 혼합하여 사용할 수 있으며, 인체의 체질, 연렬 등에 따라 종아하는 곡물을 선정하여 사용할 수 있다.Singok means rice, barley, crude oil, and yeast. It is added to give taste and flavor to medicines manufactured. It can be used by mixing at least one or more from the group consisting of various grains that can be ingested by humans. In addition, it can be used to select the seed grain according to the constitution, serialization of the human body.

신곡의 사용량은 6 ∼ 27중량% 사용되는 것이 효과적이며, 6중량% 미만으로 사용될 경우에는 제조되는 약제의 맛과 향이 부족하여 어린이들이 복용하기에 적합하지 않은 단점이 있고, 27중량%를 초과하여 사용될 경우에는 다른 성분들의 사용량이 상대적으로 감소되어 본 발명에서 목적하는 효과를 얻을 수 없으며, 360메쉬이하로 분쇄한 것을 사용하는 것이 인체에 투여된 후 흡수가 신속히 일어나고 경구 투여시에 이질감을 느끼지 않아 바람직하다.It is effective to use 6 to 27% by weight of the new song, and when used at less than 6% by weight, there is a disadvantage in that it is not suitable for children due to lack of taste and aroma of the manufactured drug, and exceeds 27% by weight When used, the amount of other ingredients is relatively reduced, so that the desired effect can not be obtained in the present invention, and the use of pulverized powder of 360 mesh or less does not cause heterogeneity during oral administration due to rapid absorption after administration to the human body. desirable.

또한, 본 발명에서는 필요에 따라 경구투여시 맛과 향이 만족스러울 정도가 되도록 당분을 제조되는 약제 중 10중량% 내외로 사용하는 것이 바람직하다.In addition, in the present invention, it is preferable to use the sugar in about 10% by weight of the drug to be prepared so that the taste and aroma are satisfactory during oral administration as necessary.

상술한 바와 같은 각각의 성분들을 균질하게 혼합하고 분말 그대로 사용하거나 환으로 제형하여 투여하거나 본 발명이 속하는 기술 분야에서 통상적으로 사용되는 방법을 이용하여 캡슐로 제조하여 적용하게 된다.Each component as described above is mixed homogeneously and used as a powder or formulated in a pill and administered or prepared into a capsule using a method commonly used in the art to which the present invention belongs.

다음의 실시예는 본 발명을 좀 더 구체적으로 설명하는 것이지만, 본 발명의 범주를 한정하는 것은 아니다.The following examples illustrate the invention in more detail, but do not limit the scope of the invention.

실시예 1Example 1

참나무 원목을 1200℃의 고열로 연소하여 가스를 완전히 제거한 백탄을 360메쉬로 분쇄한 참숯 분말 60중량%, 180메쉬로 분쇄한 찹쌀현미 15중량%에 적정량의 물을 첨가하여 에멀젼화한 것, 180메쉬로 분쇄한 백출 분말 10중량%, 180메쉬의 입도를 갖는 맥아 분말 7중량%와 누룩으로 되는 신곡 분말 8중량%를 균질하게 혼합하고 1개의 환이 0.5g이 되도록 환으로 성형하여 본 발명의 약제를 제조하였다.60% by weight of charcoal powder pulverized oak wood with high temperature of 1200 ℃ and gas completely removed, and emulsified by adding an appropriate amount of water to 60% by weight of glutinous brown rice pulverized with 180 mesh, 180% The drug of the present invention is uniformly mixed with 10% by weight of the crushed white powder, 7% by weight of malt powder having a particle size of 180 mesh, and 8% by weight of new grain powder made of yeast, and molded into a ring so that one ring is 0.5g. Was prepared.

실시예 2Example 2

찹쌀 현미를 분말 상태로 그대로 사용하고 각각의 성분을 혼합하여 캡슐에 봉입한 것을 제외하고는 실시예 1과 동일한 방법으로 캡슐 형태의 본 발명의 약제를 제조하였다.The drug of the present invention was prepared in the same manner as in Example 1, except that glutinous rice brown rice was used as it was, and each ingredient was mixed and encapsulated in a capsule.

실시예 3 ∼ 4Examples 3-4

참나무 대신에 대나무를 원목으로 사용한 것을 제외하고는 실시예 1 및 2와 동일한 방법으로 행하여 본 발명의 약제를 제조하였다.The drug of the present invention was prepared in the same manner as in Examples 1 and 2, except that bamboo was used as the solid wood instead of the oak.

실시예 5 ∼6Examples 5-6

참나무 대신에 소나무를 원목으로 사용한 것을 제외하고는 실시예1 및 2와 동일한 방법으로 행하여 본 발명의 약제를 제조하였다.The drug of the present invention was prepared in the same manner as in Examples 1 and 2, except that pine was used as the solid wood instead of the oak.

실시예 7Example 7

참나무 원목을 1200℃의 고열로 연소하여 가스를 완전히 제거한 백탄을 360메쉬로 분쇄한 참숯 분말 60중량%, 360메쉬로 분쇄한 찹쌀현미 10중량%에 적정량의 물을 첨가하여 에멀젼화한 것, 180메쉬로 분쇄한 백출 분말 8중량%, 180메쉬의 입도를 갖는 맥아 분말 6중량%와 누룩 분말 6중량% 및 설탕 10중량%를 균질하게 혼합하고 1개의 환이 1Og이 되도록 환으로 성형하여 본 발명의 약제를 제조하였다.Solid wood was burned at a high temperature of 1200 ° C, and the gas was completely emulsified by adding 60% by weight of charcoal powder pulverized with 360 mesh and 10% by weight of glutinous brown rice crushed with 360 mesh. 8% by weight of crushed white powder, 6% by weight malt powder having a particle size of 180 mesh, 6% by weight of yeast powder and 10% by weight of sugar are homogeneously mixed and molded into a ring so that one ring is 100 g of the present invention. A medicament was prepared.

실시예 8Example 8

캡슐에 봉입하지 않고 분말상으로 그대로 이용한 것을 제외하고는 실시예 2와 동일한 방법으로 본 발명의 약제를 제조하였으며, 이 경우에는 물 180cc에 20g의 분말을 첨가하고 잘 저어 음용하도록 하였다The drug of the present invention was prepared in the same manner as in Example 2, except that it was used as it was in powder form without encapsulation. In this case, 20 g of powder was added to 180 cc of water, and stirred well for drinking.

실험예 1Experimental Example 1

실시예 1의 방법으로 제조된 약제를 위장병 환자 20명, 변비가 있는 사람 20명에게 아침저녁으로 식후에 한번에 20알을 복용하는 방법으로 1달간 복용하게 한 결과, 위장병 환자의 65%인 13명이 효과가 아주 좋은 것으로 평가하였고 20%에 해당하는 4명은 효과가 있다고 평가하였으며 나머지는 좋아지고 있는 것같다고 평가하였고, 변비가 있는 사람은 90% 이상이 완치된 것으로 나타났다.As a result of taking the medicine prepared by the method of Example 1 in 20 patients with gastrointestinal diseases and 20 people with constipation for 1 month by taking 20 tablets at a time after meals in the morning and evening, 13% (65% of gastrointestinal patients) The effect was evaluated as very good. Four out of 20% said it was effective. The rest seemed to be improving. More than 90% of people with constipation were cured.

상술한 바와 같이 본 발명에서는 흡착력과 해독작용이 강한 숯 분말 40 ∼85중량%, 지방으로 오염된 불순물을 제거하는 찹쌀 현미 10 ∼ 27중량%, 비장과 위장을 보호하는 백출가루 7 ∼ 24중량%, 소화효소를 발생하는 맥아 5 ∼ 29중량% 및 위장을 열어주고 담기를 풀어주는 신곡 6 ∼ 27중량%로 구성되는 약제 조성물을 이용하여 약제를 제조하므로서 위장질환에 특히 효과적이면서 다양한 증상에 적용가능한 숯 분말을 함유하는 약제를 얻을 수 있었다.As described above, in the present invention, 40 to 85% by weight of strong charcoal powder having strong adsorption and detoxification action, 10 to 27% by weight brown rice of glutinous rice to remove impurities contaminated with fat, and 7 to 24% by weight of white powder that protects the spleen and stomach. It is particularly effective for gastrointestinal diseases and is applicable to various symptoms by preparing a medicine using a pharmaceutical composition consisting of 5 to 29% by weight of malt generating digestive enzymes and 6 to 27% by weight of new songs that open and release the stomach. A drug containing charcoal powder was obtained.

Claims (3)

숯 분말 40 ∼ 85중량%, 찹쌀 현미 10 ∼ 27중량%, 백출가루 7 ∼ 24중량%, 맥아 5 ∼ 29중량% 및 신곡 6 ∼ 27중량%로 구성되는 약제 조성물Pharmaceutical composition consisting of 40 to 85% by weight of charcoal powder, 10 to 27% by weight of glutinous rice, 7 to 24% by weight of white rice flour, 5 to 29% by weight of malt, and 6 to 27% by weight of new grains 제 1 항에 있어서, 당분이 부가적으로 10중량% 첨가됨을 특징으로 하는 약제 조성물.The pharmaceutical composition according to claim 1, wherein the sugar is additionally added 10% by weight. 제 1 항에 있어서, 숯 분말은 360메쉬 이하의 입도를 갖는 것을 특징으로 하는 약제 조성물.The pharmaceutical composition of claim 1, wherein the charcoal powder has a particle size of 360 mesh or less.
KR1019990011362A 1999-03-31 1999-03-31 manufacture method of a medicine composition contains charcoal powder KR100331885B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019990011362A KR100331885B1 (en) 1999-03-31 1999-03-31 manufacture method of a medicine composition contains charcoal powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990011362A KR100331885B1 (en) 1999-03-31 1999-03-31 manufacture method of a medicine composition contains charcoal powder

Publications (2)

Publication Number Publication Date
KR20000061959A true KR20000061959A (en) 2000-10-25
KR100331885B1 KR100331885B1 (en) 2002-04-09

Family

ID=19578481

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990011362A KR100331885B1 (en) 1999-03-31 1999-03-31 manufacture method of a medicine composition contains charcoal powder

Country Status (1)

Country Link
KR (1) KR100331885B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457820B1 (en) * 2001-06-08 2004-11-18 차순옥 The manufacturing process of edible carbon using pine charcoal
KR100457821B1 (en) * 2001-06-08 2004-11-18 차순옥 The manufacturing process of edible charcoal using pine charcoal
KR101088004B1 (en) * 2010-11-12 2011-12-01 동국대학교 산학협력단 Composition for treating irritable bowel syndrome comprising fermented herbal mixture

Also Published As

Publication number Publication date
KR100331885B1 (en) 2002-04-09

Similar Documents

Publication Publication Date Title
CN103156095B (en) Mixed feed of young broiler chickens and preparation method of feed
CN102669495B (en) Wheat type piglet 14-35-days-old compound feed and preparation method thereof
KR20150105714A (en) composition for health functional food improving joint health
CN101518580A (en) Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof
CN107349385A (en) One group is used for fermented tcm composition that live pig nonreactive cultivates and preparation method thereof
CN105395948A (en) traditional Chinese medicine additive for eel and preparation method thereof
KR102014675B1 (en) Method of producing a granular health funciotnal food
KR101826737B1 (en) A composition containing herbs extract, and manufacturing method of the same
CN104491770A (en) Traditional Chinese medicine composition for preventing and treating poultry mycotic gland and muscular gastritis
KR102197395B1 (en) The process of making healthcare composition for relieving and preventing alcoholic hangover comprising fermented Dendropanax morbifera extract and Capsosiphon fulvescens extracts
KR100331885B1 (en) manufacture method of a medicine composition contains charcoal powder
CN101085962A (en) Lophatherum gracile brongn and lalang grass wine
CN110973625A (en) Liver-protecting and sobering-up composition based on fructus cannabis and preparation method and application thereof
CN102824626A (en) Medicine combined soaking preparation for treating anaphylactic rhinitis and preparation method thereof
KR20020078467A (en) Drink for tonic liver and Manufacture process the same.
CN101869657A (en) Plaster used together with cigarettes, method for preparing same and ring containing same
CN104971316A (en) Composition for treating esophageal cancer and preparation method thereof
JP2010000070A (en) Nutritional supplement
CN101584750B (en) Compound fig preparation
CN110974881A (en) Pure plant buccal tablet for stopping smoking and its preparation method
CN110692984A (en) Rose chewable tablet for removing oral odor and preparation method thereof
CN1535708A (en) Oral aerosol for reducing or eliminating snore and its preparation method
KR100422335B1 (en) Additive for health aid food
CN104707008B (en) A kind of composite drug and preparation method for preventing chickens respiratory disease
CN104258165A (en) Pharmaceutical preparation for preventing loach from hemorrhagic disease

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20070206

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee